Synthego Receives $41,000,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fa936278-768f-4a57-b6b7-9aa42102f34a
Date
1/5/2017
Company Name
Synthego
Mailing Address
3696 Haven Ave Redwood City, CA 94063 USA
Company Description
Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering solutions. The company’s flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research.
Website
http://www.synthego.com
Transaction Type
Venture Equity
Transaction Amount
$41,000,000
Transaction Round
Series B
Proceeds Purposes
The funds will be used for growth of commercial operations, international expansion, and introduction of new products.
M&A Terms
Venture Investor
8VC
Venture Investor
AME Cloud Ventures
Venture Investor
Element Partners
Venture Investor
OS Fund
Venture Investor
Alexandria Venture Investments
Venture Investor
ZhenFund
Venture Investor
Investor